JERSEY CITY, N.J.--(BUSINESS WIRE)--Novel steroid sparing strategies for the treatment of uveitis and the prevention of corneal transplant rejection will be the subject of a Symposium, “Steroid Sparing Approaches in Immunomodulation,” sponsored by Lux Biosciences at the 9th International Congress of the International Ocular Inflammatory Society in Paris, France on Monday, September 17.
